| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/26/2012 | CA2815046A1 Human antibodies and specific binding sequences thereof for use in neurological disease |
| 04/26/2012 | CA2815041A1 Antibodies |
| 04/26/2012 | CA2814766A1 Stable and soluble antibodies |
| 04/26/2012 | CA2814373A1 Identification of antibodies specific for lyssaviruses and methods of their use |
| 04/26/2012 | CA2813796A1 Erbb3 binding antibody |
| 04/25/2012 | EP2444806A2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| 04/25/2012 | EP2444492A1 Chicken-derived anti-lox-1 antibody |
| 04/25/2012 | EP2444484A1 Method for producing antibodies using cancer cells |
| 04/25/2012 | EP2444424A1 Improved nanobodies TM for the treatment of aggregation-mediated disorders |
| 04/25/2012 | EP2444423A1 Fc variants with altered binding to FcRn |
| 04/25/2012 | EP2444422A2 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 04/25/2012 | EP2444421A1 P-Cadherin antibodies |
| 04/25/2012 | EP2444420A1 P-Cadherin antibodies |
| 04/25/2012 | EP2444419A1 P-Cadherin antibodies |
| 04/25/2012 | EP2444409A2 Compositions and methods for the treatment of immune related diseases |
| 04/25/2012 | EP2444104A2 Treatment of multiple sclerosis (MS) with campath-1H |
| 04/25/2012 | EP2444099A1 Antibodies and related molecules that bind to 161P2F10B proteins |
| 04/25/2012 | EP2443154A1 Bispecific antigen binding proteins |
| 04/25/2012 | EP2443153A1 Bispecific, tetravalent antigen binding proteins |
| 04/25/2012 | EP2443152A1 Method for assaying prodefensin-a6 for the in vitro diagnosis of colorectal cancer |
| 04/25/2012 | EP2443151A1 Anti notch-1 antibodies |
| 04/25/2012 | EP2443150A2 Anti-vegf antibodies and their uses |
| 04/25/2012 | EP2443149A1 Bace1 inhibitory antibodies |
| 04/25/2012 | EP2443148A1 Diagnostical use of peroxiredoxin 4 |
| 04/25/2012 | EP2443138A1 An antigenic peptide derived from influenza virus and a method for selecting anti-influenza virus antibody |
| 04/25/2012 | EP2442804A1 Derivatives, reagents, and immunoassay for detecting levetiracetam |
| 04/25/2012 | EP2442798A1 Lyophilized formulations for small modular immunopharmaceuticals |
| 04/25/2012 | EP2428216A9 Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 04/25/2012 | EP2245062B1 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 04/25/2012 | EP2181122B1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 04/25/2012 | EP2146727B1 High viscosity macromolecular compositions for treating ocular conditions |
| 04/25/2012 | EP2102239B1 Improved immunoglobulin libraries |
| 04/25/2012 | EP2059534B1 Engineered anti-il-23p19 antibodies |
| 04/25/2012 | EP1789447B1 Method of delivering rna interference and uses thereof |
| 04/25/2012 | EP1778284B1 Nucleic acids and corresponding proteins entitled 58p1d12 useful in detection of cancer |
| 04/25/2012 | EP1685152B1 Il-18 binding proteins |
| 04/25/2012 | EP1682581B1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 04/25/2012 | EP1610127B1 N1,n12-diacetylspermine as tumor marker |
| 04/25/2012 | EP1112084B2 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 04/25/2012 | EP0773997B2 Htk ligand |
| 04/25/2012 | CN1921878B 属于Bcl-2家族的蛋白和其片段,和它们在癌症患者中的用途 Belonging to the Bcl-2 family of proteins and their fragments, and their use in cancer patients |
| 04/25/2012 | CN1800854B Gold-labeled test paper strip for quick diagnosis of hemorrhagic fever with renal syndrome |
| 04/25/2012 | CN1788018B Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa |
| 04/25/2012 | CN1768078B Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 04/25/2012 | CN1537014B HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 04/25/2012 | CN102428105A Antibodies containing therapeutic tpo/epo mimetic peptides |
| 04/25/2012 | CN102428103A Humanized antibodies against light and uses thereof |
| 04/24/2012 | US8163890 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 04/24/2012 | US8163889 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 04/24/2012 | US8163888 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates |
| 04/24/2012 | US8163887 Using tumor associated antigen epitopes as tool to intensify immune response to cancer cell; immunotherapy; viricides; bactericides; parasiticides |
| 04/24/2012 | US8163886 such as recombinant proteins (biodrugs) made via engineered host cells; using polymers solubilizable under a given set of conditions |
| 04/24/2012 | US8163885 Humanized antibodies against human interferon-alpha |
| 04/24/2012 | US8163884 Interleukin-21 receptor binding proteins |
| 04/24/2012 | US8163883 Gene encoding labyrinthin, a marker for cancer |
| 04/24/2012 | US8163882 Polypeptide variants with altered effector function |
| 04/24/2012 | US8163881 Immunoglobulin molecules with improved characteristics |
| 04/24/2012 | US8163873 Isolated microtubule-associated protein tau peptides and kit |
| 04/24/2012 | US8163717 Dual chain synthetic heparin-binding growth factor analogs |
| 04/24/2012 | US8163701 Prodrugs of active agents |
| 04/24/2012 | US8163552 Immunoglobulin specific to tumor cells for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/24/2012 | US8163551 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| 04/24/2012 | US8163550 Enhancement of immune responses by 4-1BB-binding agents |
| 04/24/2012 | US8163530 Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320 |
| 04/24/2012 | US8163522 Human TNF receptor |
| 04/24/2012 | US8163508 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 04/24/2012 | US8163497 Anti-extended type I glycosphingolipid antibody, derivatives thereof and use |
| 04/24/2012 | US8163494 Method for assessing metastatic properties of breast cancer |
| 04/24/2012 | US8163476 CUDR as biomarker for cancer progression and therapeutic response |
| 04/24/2012 | US8163295 Outer membrane vesicles and uses thereof |
| 04/24/2012 | US8163288 S. aureus polypeptides and antibodies |
| 04/24/2012 | US8163286 Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 04/24/2012 | US8163282 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 04/24/2012 | US8163280 Antibodies to c-Met |
| 04/24/2012 | US8163279 IL3Rα antibody conjugates and uses thereof |
| 04/24/2012 | US8163269 Bioactive stents for type II diabetics and methods for use thereof |
| 04/24/2012 | CA2627593C Dopaminergic neuron proliferative progenitor cell marker nato3 |
| 04/24/2012 | CA2501757C Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents |
| 04/24/2012 | CA2452447C Antagonistic anti-htnfsf13b human antibodies |
| 04/24/2012 | CA2443391C Pharmaceutical composition of f(ab)2 antibody fragments and a process for the preparation thereof |
| 04/24/2012 | CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1) |
| 04/19/2012 | WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS |
| 04/19/2012 | WO2012051111A2 Human oncostatin m antibodies and methods of use |
| 04/19/2012 | WO2012049570A1 Human anti-tau antibodies |
| 04/19/2012 | WO2012049431A2 Use of an anti-cd20 antibody for treating primary cerebral lymphoma |
| 04/19/2012 | WO2012049278A1 Therapies for improving pulmonary function |
| 04/19/2012 | WO2012049229A1 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof |
| 04/19/2012 | WO2012048553A1 Escherichia coli tolc antigen, antibody and use thereof |
| 04/19/2012 | WO2012017322A3 Pharmaceutical composition and method of inhibiting of production or amplifying elimination of p24 protein |
| 04/19/2012 | WO2012010974A3 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| 04/19/2012 | WO2012006596A3 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| 04/19/2012 | WO2011159877A3 Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions |
| 04/19/2012 | WO2011159655A3 IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS |
| 04/19/2012 | WO2011137344A3 Anti-s1p antibody treatment of patients with ocular disease |
| 04/19/2012 | WO2011136533A3 Chromatography apparatus and method |
| 04/19/2012 | WO2011123826A3 Prevention and treatment of cast nephropathy |
| 04/19/2012 | US20120096569 Anti-il-6 antibodies,compositions, methods and uses |
| 04/19/2012 | US20120095444 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same |
| 04/19/2012 | US20120095439 Implantable therapeutic device |
| 04/19/2012 | US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |